Home Diagnostic use of cerebral and extracerebral oxysterols
Article
Licensed
Unlicensed Requires Authentication

Diagnostic use of cerebral and extracerebral oxysterols

  • Valerio Leoni , Thomas Masterman , Fariba S. Mousavi , Bengt Wretlind , Lars-Olof Wahlund , Ulf Diczfalusy , Jan Hillert and Ingemar Björkhem
Published/Copyright: June 1, 2005

Abstract

Background: 24S-Hydroxycholesterol (24OHC) and 27-hydroxycholesterol (27OHC) are two structurally similar oxysterols of different origins–the former almost exclusively formed in the brain and the latter formed to a lesser extent in the brain than in most other organs.

Hypothesis to be tested: Neuronal damage and/or demyelination causes increased flux of 24OHC from the brain into the cerebrospinal fluid (CSF), whereas a defect blood-brain barrier causes increased flux of 27OHC from the circulation into the CSF.

Methods: Isotope dilution-mass spectrometry was used to assay the two oxysterols in CSF and plasma from more than 250 patients with different neurological and geriatric diseases.

Results: The CSF-levels of the two oxysterols were much more affected by the different diseases than the plasma levels. Patients with active demyelinating diseases had increased levels of 24OHC in CSF with a relatively high 24OHC/27OHC ratio. Patients with meningitis in general had high levels of both steroids with a low 24OHC/27OHC ratio. Patients with Alzheimer's disease had slightly increased levels of 24OHC in CSF with less increase in 27OHC. Patients with multiple sclerosis had a tendency to have higher levels of 24OHC during active periods with a high 24OHC/27OHC ratio.

Conclusions: Measurements of the two oxysterols in CSF and plasma may add significantly to existing biochemical methods for evaluation of neurological diseases.

Published Online: 2005-6-1
Published in Print: 2004-2-18

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
  2. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
  3. Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
  4. Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
  5. Antioxidants in patients with hyperthyroidism
  6. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
  7. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
  8. Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
  9. Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
  10. Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
  11. Diagnostic use of cerebral and extracerebral oxysterols
  12. Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
  13. The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
  14. Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
  15. Testing and validating a homogeneous immunometric assay for interference
  16. Linearity evaluation of analytical methods that count particles
  17. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
  18. Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
  19. Distribution of low-density lipoprotein particle size in healthy Korean adult males
  20. Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
  21. The phenomenon of regression-toward-the-mean
  22. Error messages when calculating chi-square statistics with Microsoft EXCEL®
  23. Meetings and Awards
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.034/html
Scroll to top button